No Picture
News

MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in China

LA JOLLA, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the?NASDAQ Global Market?(NASDAQ:MNOV) and the JASDAQ Market of the?Tokyo Stock Exchange?(Code Number: 4875), today announced that it has rec… […]

No Picture
News

AnaptysBio Reports Positive Topline Data from Interim Analysis of GALLOP Phase 2 Clinical Trial of ANB019 Monotherapy in Moderate-to-Severe Generalized Pustular Psoriasis

SAN DIEGO, Sept. 30, 2019 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced positive topli… […]

No Picture
News

?We are desperate for new therapies?

Experts discuss AML during the Sanford Burnham Prebys community lecture series?

Bill Veljovich had never been sick in his life. ?Not even joint pain,? shared the 80-year-old retired engineer at our recent Fleet Science Center discussion about acute my… […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Ribometrix Announces $7.8 Million in New Funding to Advance RNA-Targeting Drug Discovery Platform

DURHAM, N.C.–(BUSINESS WIRE)–Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, today announced $7.8 million in additional funding from existing investors, the Dementia Discove… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Lineage Cell Therapeutics to Present at 2019 Cantor Global Healthcare Conference on October 4, 2019

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that Brandi L. Roberts, Ch… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

ACADIA Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference on October 2, 2019

SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today ann… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

SAN DIEGO–(BUSINESS WIRE)– #TCT2019–FIH data shows that RUC-4, a novel subcutaneous platelet GPIIb/IIIa inhibitor, resulted in a potent, rapid, and sustained platelet inhibition effect. […]

No Picture
News

CEO of INmune Bio Inc. Discusses Company Accomplishments at Nasdaq?s MarketSite and Announces Presentation at World Immunotherapy Congress

La Jolla, CA., Sept. 24, 2019 (GLOBE NEWSWIRE) — ?INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient?s innate immune system to fight disease, today announced that RJ Tesi, M.D., Co-Founde… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

ACADIA Pharmaceuticals Announces that The Journal of Clinical Psychiatry Publishes Positive Phase 2 CLARITY Results for Pimavanserin as Adjunctive Treatment for Patients with Major Depressive Disorder

SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), announced today that positive results from the Phase 2 CLARITY study evaluating pimavanserin as adjunctive treatment in patients with major depressive disorder (MDD) have been publ… […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

INmune Bio to Present XPro1595 for Treating Neuroinflammation in Alzheimer?s Disease at 2019 Alzheimer?s Association International Conference (AAIC) Satellite Symposium

LA JOLLA, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), an immunotherapy company developing treatments which harness the patient?s innate immune system to fight disease, announced today that the company will be presentin… […]

No Picture
News

?We are desperate for new therapies?: Experts discuss AML during the Sanford Burnham Prebys community lecture series

Bill Veljovich had never been sick in his life. ?Not even joint pain,? shared the 80-year-old retired engineer at our recent Fleet Science Center discussion about acute myeloid leukemia (AML), a life-threatening type of blood cancer. He was joined by e… […]